Literature DB >> 11685804

The natural history of hepatitis C virus infection.

E Kenny-Walsh1.   

Abstract

The natural history of HCV infection remains ill-defined. The knowledge accumulated on the progression of HCV to date is important, however. It is now abundantly clear that the progression of disease is generally slow, and the development of cirrhosis and its complications is a possibility, not a probability as hitherto thought. Predicting the outcome remains a quandary for clinicians. Ultimately it will be possible to define the natural history of hepatitis C infection through a combination of research in the fields of virology, immunology, and molecular biology and by monitoring the biochemical and histologic progress of the disease. Only then will it be possible to intervene appropriately and develop new therapies to prevent the progression to cirrhosis and hepatocellular carcinoma.

Entities:  

Mesh:

Year:  2001        PMID: 11685804     DOI: 10.1016/s1089-3261(05)70204-x

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  10 in total

1.  Associating conditional cash transfer to universal access to treatment could be the solution to the HCV epidemic among drug users (DUs).

Authors:  Philippe Chossegros; Fiorant Di Nino
Journal:  Harm Reduct J       Date:  2018-12-12

Review 2.  Managing occupational risks for hepatitis C transmission in the health care setting.

Authors:  David K Henderson
Journal:  Clin Microbiol Rev       Date:  2003-07       Impact factor: 26.132

3.  In vitro phenotypic characterization of hepatitis C virus NS3 protease variants observed in clinical studies of telaprevir.

Authors:  Min Jiang; Nagraj Mani; Chao Lin; Andrzej Ardzinski; Michelle Nelson; Dugan Reagan; Doug Bartels; Yi Zhou; Olivier Nicolas; B Govinda Rao; Ute Müh; Brian Hanzelka; Ann Tigges; Rene Rijnbrand; Tara L Kieffer
Journal:  Antimicrob Agents Chemother       Date:  2013-10-07       Impact factor: 5.191

4.  Monitoring the antiviral effect of alpha interferon on individual cells.

Authors:  Chon Saeng Kim; Jong Ha Jung; Takaji Wakita; Seung Kew Yoon; Sung Key Jang
Journal:  J Virol       Date:  2007-05-30       Impact factor: 5.103

5.  Hepatitis C virus non-structural protein NS3 interacts with LMP7, a component of the immunoproteasome, and affects its proteasome activity.

Authors:  Yee-Ling Khu; Yee-Joo Tan; Seng Gee Lim; Wanjin Hong; Phuay-Yee Goh
Journal:  Biochem J       Date:  2004-12-01       Impact factor: 3.857

6.  Identification of AP80978, a novel small-molecule inhibitor of hepatitis C virus replication that targets NS4B.

Authors:  Jodi Dufner-Beattie; Andrew O'Guin; Stephanie O'Guin; Aaron Briley; Bin Wang; Jennifer Balsarotti; Robert Roth; Gale Starkey; Urszula Slomczynska; Amine Noueiry; Paul D Olivo; Charles M Rice
Journal:  Antimicrob Agents Chemother       Date:  2014-04-07       Impact factor: 5.191

7.  Phenotypic characterization of resistant Val36 variants of hepatitis C virus NS3-4A serine protease.

Authors:  Yi Zhou; Doug J Bartels; Brian L Hanzelka; Ute Müh; Yunyi Wei; Hui-May Chu; Ann M Tigges; Debra L Brennan; B Govinda Rao; Lora Swenson; Ann D Kwong; Chao Lin
Journal:  Antimicrob Agents Chemother       Date:  2007-10-15       Impact factor: 5.191

8.  San-Huang-Xie-Xin-Tang extract suppresses hepatitis C virus replication and virus-induced cyclooxygenase-2 expression.

Authors:  J C Lee; C K Tseng; S F Wu; F R Chang; C C Chiu; Y C Wu
Journal:  J Viral Hepat       Date:  2011-01-20       Impact factor: 3.728

Review 9.  Anti-infective potential of catechins and their derivatives against viral hepatitis.

Authors:  Jae-Min Song
Journal:  Clin Exp Vaccine Res       Date:  2018-01-29

10.  Correlation of Apolipoprotein B mRNA-editing Enzyme, Catalytic Polypeptide- like 3G Genetic Variant rs8177832 with HIV-1 Predisposition in Pakistani Population.

Authors:  Khurshid Iqbal; Muhammad Imran; Shafi Ullah; Muhsin Jamal; Yasir Waheed
Journal:  Curr HIV Res       Date:  2018       Impact factor: 1.581

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.